Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

Core Viewpoint - Myriad Genetics, Inc. will hold its fourth quarter and full year 2024 earnings conference call on February 24, 2025, providing a financial overview and business update [1] Upcoming Investor Conferences - Management will participate in three upcoming investor healthcare conferences: - TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 9:50 am ET [4] - Raymond James 46th Annual Institutional Investors Conference on March 4, 2025, at 4:00 pm ET [4] - Leerink Global Healthcare Conference on March 10, 2025, at 2:20 pm ET [4] Company Overview - Myriad Genetics is a leader in genetic and genomic tumor testing and precision medicine, focusing on advancing health and well-being [3] - The company develops genetic tests that assess disease risk and guide treatment decisions, aiming to improve patient care and reduce healthcare costs [3]